Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.62
+0.11 (1.29%)
Mar 11, 2026, 3:16 PM EDT - Market open

Passage Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2838365575344
Market Cap Growth
-13.56%4.76%-35.39%-26.37%-78.12%-70.47%
Enterprise Value
5.0111.7-19.12-35.88-90.4128.68
Last Close Price
8.6211.8011.3420.2027.60127.00
PE Ratio
--0.82-0.54-0.54-0.55-1.82
PB Ratio
1.442.000.590.500.371.08
P/TBV Ratio
1.462.000.570.500.371.06
P/FCF Ratio
--1.19-0.75-0.71-0.63-2.38
P/OCF Ratio
--1.19-0.75-0.71-0.64-2.71
EV/EBITDA Ratio
--0.240.280.340.67-0.16
EV/EBIT Ratio
--0.240.270.330.65-0.15
EV/FCF Ratio
--0.370.400.460.75-0.20
Debt / Equity Ratio
1.091.090.360.210.120
Debt / EBITDA Ratio
-0.49-0.49-0.38-0.25-0.20-
Debt / FCF Ratio
-0.76-0.76-0.53-0.33-0.22-
Net Debt / Equity Ratio
-1.19-1.19-0.84-0.79-0.81-0.99
Net Debt / EBITDA Ratio
0.460.460.760.841.211.71
Net Debt / FCF Ratio
0.710.711.071.121.352.19
Quick Ratio
2.012.013.966.9910.3310.70
Current Ratio
2.072.074.077.2210.7411.02
Return on Equity (ROE)
-113.78%-113.78%-75.08%-65.29%-52.35%-59.48%
Return on Assets (ROA)
-59.86%-59.86%-55.66%-55.01%-46.24%-54.38%
Return on Invested Capital (ROIC)
-346.92%-346.92%-339.36%-348.82%-568.73%-3142.62%
Return on Capital Employed (ROCE)
-80.65%-80.65%-64.81%-60.32%-50.25%-58.74%
Earnings Yield
-166.76%-121.61%-185.54%-184.16%-181.16%-54.80%
FCF Yield
-115.42%-83.90%-133.86%-141.30%-159.86%-41.96%
Buyback Yield / Dilution
-0.06%-0.06%-24.75%-0.24%-0.57%-48.48%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q